Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asimadoline for On-demand Treatment of IBS Pain
NCT00955994Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2005
- Primary completion
- Mar 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of asimadoline in irritable bowel syndrome (IBS), sponsored by Mayo Clinic. Primary endpoint: Severity of abdominal pain 2 hours after treatment. Started Jan 2005; status: completed.
02
Drugs
asimadoline
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00955994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955994.